Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoma, T-Cell, Cutaneous × liposomal doxorubicin × Clear all

Sponsor

Conditions

Ovarian Neoplasms 27 Breast Neoplasms 19 Fallopian Tube Neoplasms 18 Multiple Myeloma 14 Carcinoma, Ovarian Epithelial 12 Lymphoma 7 Triple Negative Breast Neoplasms 4 Neoplasms, Plasma Cell 3 Prostatic Neoplasms 2 Neoplasms 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Large B-Cell, Diffuse 2 Hodgkin Disease 2 Burkitt Lymphoma 2 Subcutaneous panniculitis-like T-cell lymphoma 1 Solid Tumors 1 Sarcoma, Synovial 1 Sarcoma, Kaposi 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Peritoneal Neoplasms 1 Patient Participation 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neurofibrosarcoma 1 Neuroendocrine Tumors 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1

Interventions

fludarabine phosphate 20 Peripheral Blood Stem Cell Transplantation 16 Whole-Body Irradiation 15 Mycophenolic Acid 14 Cyclophosphamide 13 Antilymphocyte Serum 13 Busulfan 12 Tacrolimus 11 Cyclosporine 11 Melphalan 9 Methotrexate 8 Rituximab 7 Etoposide 7 Flow Cytometry 6 Filgrastim 6 romidepsin 5 Vorinostat 5 Dexamethasone 5 thymoglobulin 4 Sirolimus 4 Granulocyte Colony-Stimulating Factor 4 Calcium Dobesilate 4 Bexarotene 4 Alemtuzumab 4 fludarabine 3 Therapeutics 3 Lenalidomide 3 Everolimus 3 Cord Blood Stem Cell Transplantation 3 Carboplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡